Evidence map›Paper›PMID 33575478›Full record

ArticleMolecular therapy oncolytics2021

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of

Nazneen Aslam, Elham Abusharieh, Duaa Abuarqoub, Dema Ali, Dana Al-Hattab, Suha Wehaibi, Ban Al-Kurdi, Fatima Jamali, Walhan Alshaer, Hanan Jafar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy oncolytics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Nazneen AslamCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Elham AbushariehCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Duaa AbuarqoubCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Dema AliCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Dana Al-HattabCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Suha WehaibiCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Ban Al-KurdiCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Fatima JamaliCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Walhan AlshaerCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Hanan JafarCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
Abdalla S AwidiCell Therapy Center, The University of Jordan, Amman 11942, Jordan.
University of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer stem cells (CSCs) use their stemness properties to perpetuate their lineage and survive chemotherapy. Currently cell-based and cell-free therapies are under investigation to develop novel anti-cancer treatment modalities. We designed this study to investigate how cell extracts of mesenchymal stem cells affect the growth of glioma stem cells

Indexed as

BM-MSCsconditioned mediaCSC arraysglioma stem cellsgliospheresmesenchymal stem cellsmicroarraysignaling pathwaysstemnessWJ-MSCs

Identifiers

PMID33575478
PMCPMC7851499
OpenAlexW3107643383

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.